Mobile

A prospective, randomized, open-label, active-controlled study in adult subjects with acute bacterial sinusitis comparing the clinical efficacy of telithromycin (KETEK®) 800 mg once a day for 5 days ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-001460-42

A prospective, randomized, open-label, active-controlled study in adult subjects with acute bacterial sinusitis comparing the clinical efficacy of telithromycin (KETEK®) 800 mg once a day for 5 days versus amoxicillin-clavulanic acid (AUGMENTIN®) 875/125 mg twice a day for 10 days

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

to demonstrate that the clinical efficacy of Ketek® 800 mg OD for 5 days is noninferior to Augmentin® 875/125 mg BID for 10 days at the test of cure visit (Day 17-21).

Critère d'inclusion

  • acute bacterial sinusitis (ABS)

Liens